Eu Ivdd Eu Ivd General No Longer On The Market 🇹🇼 Taiwan

Eclipse A1C

Apex Biotechnology Corp. · 🇹🇼 Taiwan
Devices (same UDI-DI)
1
Certificates
0
Countries
0
Notified Bodies
0

Basic Information

Primary DI
D-47136487600B05F
Basic UDI-DI Code
B-47136487600B05F
Reference
S54133, S54144, S54145, S54119
Device Types
Single use
Regulation
Eu Ivdd
Classification
Eu Ivd General
Status
No Longer On The Market

Additional Description

The Eclipse A1c™ Analyzer is intended to be used for the measurement of the percent of Glycohemoglobin (%HbA1c) in capillary (fingerstick) or venous whole blood. It is intended for professional, in vitro diagnostic use and must be used according to the Instructions provided by manufacturer. The Eclipse A1c™ Analyzer could be used in physician offices, laboratories, clinics, hospitals, and could save valuable time in proper control of diabetes. The Diabetes Control and Complications Trial (DCCT) showed the importance of improved glycemic control in reducing the risk and progression of the complications of diabetes. The American Diabetes Association (ADA) recommends measurement of HbA1c level to four times per year, less frequently in patients with stable control.

CND Nomenclature Codes

Code Description
W0201060101 GLYCOSILATED HEMOGLOBIN DEVICEs
W0101060107 HBA1C TEST STRIPS

Similar Devices

Other on-the-market devices with the same classification (Eu Ivd General) and regulation (EU IVDD).

View all